Cover Image
市場調查報告書

VBI Vaccines - 產品平台分析

VBI Vaccines Inc. - Product Pipeline Review - 2015

出版商 Global Markets Direct 商品編碼 256042
出版日期 內容資訊 英文 21 Pages
訂單完成後即時交付
價格
Back to Top
VBI Vaccines - 產品平台分析 VBI Vaccines Inc. - Product Pipeline Review - 2015
出版日期: 2015年08月12日 內容資訊: 英文 21 Pages
簡介

VBI Vaccines是致力於研發為治療傳染病用疫苗新藥的生物科技企業。特別致力於開發季節性及全球性流感、肝炎,HIV等傳染病的疫苗。

本報告提供VBI Vaccines的治療藥開發平台現狀及各開發階段比較分析,提供您藥物標的,作用機制,給藥途徑,各分子類型的治療藥評估,最新的企業新聞和發表,後期階段及中止的計劃等相關資訊。

VBI Vaccines 基本資料

VBI Vaccines 概要

  • 主要資訊
  • 企業資料

VBI Vaccines :R&D概要

  • 主要的治療範圍

VBI Vaccines :開發平台的檢討

  • 各開發階段的開發中產品
  • 單劑產品

VBI Vaccines :開發中產品概況

  • 初期階段產品開發中產品
    • 前臨床階段的產品/聯合治療模式

VBI Vaccines :藥物簡介

  • CMV Vaccine
  • Vaccine For Infectious Diseases
  • VBI-1502A

VBI Vaccines :開發平台分析

  • 各給藥途徑
  • 各分子類型

VBI Vaccines :暫停中的計劃

VBI Vaccines :總公司和子公司的所地

附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GMDHC07522CDB

Summary

Global Markets Direct's, 'VBI Vaccines Inc. - Product Pipeline Review - 2015', provides an overview of the VBI Vaccines Inc.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of VBI Vaccines Inc.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of VBI Vaccines Inc. including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of VBI Vaccines Inc.'s human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the VBI Vaccines Inc.'s pipeline products

Reasons to buy

  • Evaluate VBI Vaccines Inc.'s strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of VBI Vaccines Inc. in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the VBI Vaccines Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of VBI Vaccines Inc. and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of VBI Vaccines Inc.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of VBI Vaccines Inc. and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • VBI Vaccines Inc. Snapshot
    • VBI Vaccines Inc. Overview
    • Key Information
    • Key Facts
  • VBI Vaccines Inc. - Research and Development Overview
    • Key Therapeutic Areas
  • VBI Vaccines Inc. - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
  • VBI Vaccines Inc. - Pipeline Products Glance
    • VBI Vaccines Inc. - Early Stage Pipeline Products
      • Preclinical Products/Combination Treatment Modalities
  • VBI Vaccines Inc. - Drug Profiles
    • FLU-LPV
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • hepatitis C vaccine
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • rabies vaccine
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • VBI-1501A
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • VBI Vaccines Inc. - Pipeline Analysis
    • VBI Vaccines Inc. - Pipeline Products by Target
    • VBI Vaccines Inc. - Pipeline Products by Route of Administration
    • VBI Vaccines Inc. - Pipeline Products by Molecule Type
  • VBI Vaccines Inc. - Recent Pipeline Updates
  • VBI Vaccines Inc. - Dormant Projects
  • VBI Vaccines Inc. - Locations And Subsidiaries
    • Head Office
    • Other Locations & Subsidiaries
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • VBI Vaccines Inc., Key Information
  • VBI Vaccines Inc., Key Facts
  • VBI Vaccines Inc. - Pipeline by Indication, 2015
  • VBI Vaccines Inc. - Pipeline by Stage of Development, 2015
  • VBI Vaccines Inc. - Monotherapy Products in Pipeline, 2015
  • VBI Vaccines Inc. - Preclinical, 2015
  • VBI Vaccines Inc. - Pipeline by Target, 2015
  • VBI Vaccines Inc. - Pipeline by Route of Administration, 2015
  • VBI Vaccines Inc. - Pipeline by Molecule Type, 2015
  • VBI Vaccines Inc. - Recent Pipeline Updates, 2015
  • VBI Vaccines Inc. - Dormant Developmental Projects,2015
  • VBI Vaccines Inc., Other Locations

List of Figures

  • VBI Vaccines Inc. - Pipeline by Top 10 Indication, 2015
  • VBI Vaccines Inc. - Pipeline by Top 10 Molecule Type, 2015
Back to Top